PATENT CLAIM ANALYSIS

Application Number: 16087947
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "053000"]

Abstract:
The present invention provides a medicament useful for treatment and/or prevention of cancer, a vaccine adjuvant, and an inhibitor of immune checkpoint comprising a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein Bonds a-d, Ring A, R 1 , R 1′ , R 2 , R 2′ , R 3 -R 8 , and n are as defined in the present specification.

Claim (Index 12):
The compound of  claim 1  or a pharmaceutically acceptable salt thereof, wherein the compound is

Metadata:
- Claim Count in Document: 36.0
- Percentile: 97.0
- Lexical Diversity: 1.37037
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15766985', '14238507', '10932463', '11587906', '15799771']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7748230677054777
- 35 USC 102 Novelty (BERT): 0.5186889982700245
- Combined Prediction Score: 0.7492096607619324
- Mean Citation Score: 319.059382
- Max Citation Score: 326.9722
- Similarity Product: 308.9612665731907

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test